TUMOR HETEROGENEITY AND DRUG-RESISTANCE

被引:203
作者
DEXTER, DL
LEITH, JT
机构
[1] DUPONT CO, DEPT BIOMED PROD, DIV PHARMACEUT, CANC CHEMOTHERAPY PROGRAM, WILMINGTON, DE 19898 USA
[2] RHODE ISL HOSP, DEPT RADIAT MED, PROVIDENCE, RI 02902 USA
[3] BROWN UNIV, DIV BIOL & MED, PROVIDENCE, RI 02912 USA
关键词
D O I
10.1200/JCO.1986.4.2.244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:244 / 257
页数:14
相关论文
共 139 条
[1]   CHANGES IN MORPHOLOGIC AND BIOCHEMICAL CHARACTERISTICS OF SMALL CELL-CARCINOMA OF THE LUNG - CLINICOPATHOLOGIC STUDY [J].
ABELOFF, MD ;
EGGLESTON, JC ;
MENDELSOHN, G ;
ETTINGER, DS ;
BAYLIN, SB .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (05) :757-764
[2]   RADIOSENSITIZERS - A CONFERENCE PREVIEW [J].
ADAMS, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (08) :1181-1184
[3]   DIFFERENTIAL RESPONSE BY HUMAN MELANOMA CELLS TO 1,3-BIS-(2-CHLOROETHYL)-1-NITROSOUREA AND BLEOMYCIN [J].
BARRANCO, SC ;
DREWINKO, B ;
HUMPHREY, RM .
MUTATION RESEARCH, 1973, 19 (02) :277-280
[4]   VARIABLE CONTENT OF HISTAMINASE, L-DOPA DECARBOXYLASE AND CALCITONIN IN SMALL-CELL CARCINOMA OF LUNG - BIOLOGIC AND CLINICAL IMPLICATIONS [J].
BAYLIN, SB ;
WEISBURGER, WR ;
EGGLESTON, JC ;
MENDELSOHN, G ;
BEAVEN, MA ;
ABELOFF, MD ;
ETTINGER, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (03) :105-110
[5]   DETECTION OF P-GLYCOPROTEIN IN OVARIAN-CANCER - A MOLECULAR MARKER ASSOCIATED WITH MULTIDRUG RESISTANCE [J].
BELL, DR ;
GERLACH, JH ;
KARTNER, N ;
BUICK, RN ;
LING, V .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) :311-315
[6]  
BERTINO JR, 1983, CANCER TREAT REP, V67, P901
[7]  
BERTINO JR, 1985, J CLIN ONCOL, V3, P293
[8]  
BICHEL P, 1982, CANCER-AM CANCER SOC, V50, P1771, DOI 10.1002/1097-0142(19821101)50:9<1771::AID-CNCR2820500921>3.0.CO
[9]  
2-7
[10]   ON HETEROGENEITY OF NON-HODGKINS LYMPHOMAS AS REGARDS SENSITIVITY TO CYTOSTATIC DRUGS - AN INVITRO STUDY [J].
BIORKLUND, A ;
HAKANSSON, L ;
STENSTAM, B ;
TROPES, C ;
AKERMAN, M .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (05) :647-654